Adjunctive Local Application of Lidocaine During Scleral Buckling Under General Anesthesia

NCT ID: NCT01417572

Last Updated: 2011-08-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effect of topical lidocaine in scleral buckling surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Detachment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lidocaine

Group Type EXPERIMENTAL

lidocaine

Intervention Type DRUG

to evaluate the effect of lidocaine on oculocardiac reflex during the surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

lidocaine

to evaluate the effect of lidocaine on oculocardiac reflex during the surgery

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Retinal detachment
* Retinal tear less than 3 hour clock

Exclusion Criteria

* Vitreous hemorrhage
* Proliferative vitreoretinopathy
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Isfahan University of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

isfahan university of medical sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Isfahan University of Medical Sciences

Isfahan, Isfahan, Iran

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Iran

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amin Masjedi, MD

Role: CONTACT

+983112211915

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

amin masjedi, MD

Role: primary

+983112211915

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

199

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oral Sedation in Vitreoretinal Surgery
NCT04346095 UNKNOWN PHASE4
Decorin in Sub Scleral Trabeculectomy
NCT03924544 UNKNOWN PHASE1